期刊文献+

基于阳离子表面活性剂/核酸适配体的超分子组装体荧光检测Hg(Ⅱ)的研究 被引量:1

Fluorescence Detection of Hg(Ⅱ) Based on Supramolecular Assembly of Cationic Surfactant/Hg(Ⅱ) Aptamer
下载PDF
导出
摘要 采用带正电的表面活性剂十二烷基三甲基溴化铵(DTAB)与带负电的Hg(Ⅱ)核酸适配体(5′-TTCTTTCTTCCCTTGTTTGTT-3′),通过静电作用与疏水作用结合为超分子组装体,在组装体中包埋荧光染料尼罗红作为荧光探针。当加入待测物Hg(Ⅱ)后,Hg(Ⅱ)与胸腺嘧啶T形成"T-Hg(Ⅱ)-T"发夹状结构,从而诱导其解组装。利用尼罗红在水环境与疏水腔中荧光强度的不同构建"荧光关"的Hg(Ⅱ)的检测体系。该检测体系对Hg(Ⅱ)的检出限达到5.1×10-12 mol·L-1,线性检测范围为1.0×10-11~1.0×10-10 mol·L-1。其它离子对检测体系的影响可基本忽略不计,检测体系具有良好的选择性。方法可用于自来水中Hg(Ⅱ)的检测,回收率为92%~107%。 Driven by electrostatic and hydrophobic interaction,positively charged surfactant N,N,N-trimethyl-1-dodecanaminium bromide(DTAB) and negatively charged Hg(Ⅱ) aptamer(5′-TTCTTTCTTCCCTTGTTTGTT-3′) would form micellar-type assemblies.The hydrophobic dye nile red was encapsulated in the apolar interiors of the supramolecular assemblies as a fluorescent probe.Upon addition of target Hg(Ⅱ),the Hg(Ⅱ) aptamer with thymine(T)-rich sequences selectively bound with Hg(Ⅱ) to form an Hg(Ⅱ)-bridged T base pair and the aptamer changed into a hairpin-like structure.The fluorescence of nile red was turned off due to the disassembling of the supramolecular assemblies.The detection limit of Hg(Ⅱ) was as low as 5.1×10-12 mol·L-1 with a good selectivity,and the linear detection range was from 1.0×10-11 to 1.0×10-10 mol·L-1.This method revealed good recovery rates from 92% to 107% in tap water.
作者 高菲 贾兰 陈松 GAO Fei;JIA Lan;CHEN Song(College of Materials Science and Engineering,Taiyuan University of Technology,Taiyuan 030024)
出处 《分析科学学报》 CAS CSCD 北大核心 2019年第5期607-611,共5页 Journal of Analytical Science
基金 国家自然科学基金(No.51303124) 山西省回国留学基金(No.2016-024)
关键词 表面活性剂 Hg(Ⅱ)核酸适配体 尼罗红 “荧光关” Surfactant Hg(Ⅱ) aptamer Nile red "Fluorescence turn-off"
  • 相关文献

参考文献5

二级参考文献124

  • 1陶澍,陈伟元.深圳地区土壤汞含量分布及污染[J].中国环境科学,1993,13(1):35-38. 被引量:17
  • 2郭翠花,王应刚,任艳萍,史俊华.太原市地表土汞含量的分布特征[J].山西大学学报(自然科学版),1996,19(3):339-344. 被引量:14
  • 3王定勇,李孝华,吴成.重庆大气汞初步调查[J].重庆环境科学,1996,18(4):58-61. 被引量:33
  • 4张彦明,齐雪茹,赵全刚,刘建成.陕西省部分市县鱼肉蛋奶中汞含量的检测分析[J].西北农业大学学报,1997,25(2):61-65. 被引量:3
  • 5苏拔贤.生物化学制备技术[M].北京:科学出版社,1994.44-46.
  • 6Burmeistor PE,Lewis SD,Silva RF,et al.Direct in vitro selection of a 2'-O-methyl aptamer to VEGF[J].Chem Biol,2005,12(1):25-33.
  • 7Oney S,Lam RTS,Bompiani KM,et al.Development of universal antidotes to control aptamer activity[J].Nat Med,2009,15(10):1224-1228.
  • 8Rusconi CP,Roberts JD,Pitoc GA,et al.Antidote-mediated control of an anticoagulant aptamer in vivo[J].Nat Biotechnol,2004,22(11):1423-1428.
  • 9Dyke CK,Steinhubl SR,Kleiman NS,et al.First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology-a phase 1A pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor Ⅺa activity[J].Circulation,2006,114(23):2490-2497.
  • 10Chan MY,Cohen MG,Dyke CK,et al.Phase 1B randomized study of antidote-controlled modulation of factor Ⅺ a activity in patients with stable coronary artery disease[J].Circulation,2008,117(22):2865-2874.

共引文献61

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部